Skip to content

Clinical trials

Withdrawn Neuroblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Status: Withdrawn Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20102
20111
20161
20172
20181
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Baylor College of Medicine1
Emory University1
Giselle Sholler1
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)1
Mayo Clinic1
Molecular Insight Pharmaceuticals, Inc.1
NYU Langone Health1
Nationwide Children's Hospital1
Theodore Laetsch1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma13
Osteosarcoma3
Sarcoma3
Central Nervous System Neoplasms2
Lymphoma2
Recurrence2
Wilms Tumor2
Blast Crisis1
Brain Neoplasms1
Breast Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.